New Zealand markets closed
  • NZX 50

    12,211.96
    +82.98 (+0.68%)
     
  • NZD/USD

    0.6335
    +0.0006 (+0.09%)
     
  • ALL ORDS

    7,740.50
    +27.40 (+0.36%)
     
  • OIL

    77.50
    +0.36 (+0.47%)
     
  • GOLD

    1,891.70
    +6.90 (+0.37%)
     

What Is Stryker Corporation's (NYSE:SYK) Share Price Doing?

Let's talk about the popular Stryker Corporation (NYSE:SYK). The company's shares saw a double-digit share price rise of over 10% in the past couple of months on the NYSE. With many analysts covering the large-cap stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. However, what if the stock is still a bargain? Let’s take a look at Stryker’s outlook and value based on the most recent financial data to see if the opportunity still exists.

Check out our latest analysis for Stryker

Is Stryker Still Cheap?

The stock seems fairly valued at the moment according to my valuation model. It’s trading around 6.2% below my intrinsic value, which means if you buy Stryker today, you’d be paying a reasonable price for it. And if you believe the company’s true value is $248.12, then there isn’t much room for the share price grow beyond what it’s currently trading. What's more, Stryker’s share price may be more stable over time (relative to the market), as indicated by its low beta.

What does the future of Stryker look like?

earnings-and-revenue-growth
earnings-and-revenue-growth

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. With profit expected to grow by 45% over the next couple of years, the future seems bright for Stryker. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

What This Means For You

Are you a shareholder? It seems like the market has already priced in SYK’s positive outlook, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the track record of its management team. Have these factors changed since the last time you looked at the stock? Will you have enough confidence to invest in the company should the price drop below its fair value?

Are you a potential investor? If you’ve been keeping an eye on SYK, now may not be the most advantageous time to buy, given it is trading around its fair value. However, the positive outlook is encouraging for the company, which means it’s worth further examining other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. While conducting our analysis, we found that Stryker has 2 warning signs and it would be unwise to ignore these.

If you are no longer interested in Stryker, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here